Boothbay Fund Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Boothbay Fund Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-41,700	Closed	-$1.26M	–	2629
2026 Q1	$1.26M	Buy	+41,700	New	+$1.34M	0.02%	826
2025 Q4	–	Sell	-58,600	Closed	-$1.18M	–	2360
2025 Q3	$1.18M	Hold	58,600	–	–	0.02%	759
2025 Q2	$982K	Hold	58,600	–	–	0.02%	686
2025 Q1	$901K	Buy	58,600 +29,700	+103%	+$531K	0.02%	667
2024 Q4	$637K	Buy	+28,900	New	+$526K	0.02%	791

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Boothbay Fund Management's TEVA Position: Q2 2026 in Review

Boothbay Fund Management increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 2.9% in Q2 2026, buying an estimated $84.9K and bringing the position to 90,928 shares worth $3.08M. The position accounts for 0.04% of the portfolio, ranked #521.

Boothbay Fund Management first reported a position in TEVA in Q1 2015 and has held it in 13 quarters since. The position peaked at $4.03M in Q3 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Boothbay Fund Management held 90,928 shares of Teva Pharmaceutical Industries Limited worth $3.08M as of Q2 2026.
Boothbay Fund Management bought 2,549 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $84.9K.
Teva Pharmaceutical Industries Limited made up 0.04% of Boothbay Fund Management's portfolio in Q2 2026, its #521 holding.
Boothbay Fund Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2015 and has held it in 13 quarters since.
Boothbay Fund Management's Teva Pharmaceutical Industries Limited position peaked at $4.03M in Q3 2025.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.